Genetic Testing Market in APAC 2022-2026

Genetic Testing Market in APAC 2022-2026

Technavio has been monitoring the genetic testing market in APAC and it is poised to grow by $ 1.31 bn during 2022-2026, progressing at a CAGR of 13.21% during the forecast period. Our report on the genetic testing market in APAC provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. The market is driven by rising approval of advanced genetic testing products and increasing application of genetic testing in oncology. In addition, rising approval of advanced genetic testing products is anticipated to boost the growth of the market as well.

The genetic testing market in APAC analysis includes product and application segments.

Technavio's genetic testing market in APAC is segmented as below:

• By Product
• Equipment
• Consumables
• By Application
• Cancer diagnosis
• Genetic disease diagnosis
• Cardiovascular disease diagnosis
• Others

This study identifies the rising strategic partnershipas one of the prime reasons driving the genetic testing market growth in APAC during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on genetic testing market in APAC covers the following areas:

• Genetic testing market sizing
• Genetic testing market forecast
• Genetic testing market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading genetic testing market vendors in APAC that include Abbott Laboratories, Bio Rad Laboratories Inc., Danaher Corp., Exact Sciences Corp., F. Hoffmann-La Roche Ltd., Illumina Inc., Mapmygenome India Ltd., Myriad Genetics Inc., QIAGEN NV, and Thermo Fisher Scientific Inc. Also, the genetic testing market in APAC analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Companies Mentioned

Abbott Laboratories, Bio Rad Laboratories Inc., Danaher Corp., Exact Sciences Corp., F. Hoffmann-La Roche Ltd., Illumina Inc., Mapmygenome India Ltd., Myriad Genetics Inc., QIAGEN NV, Thermo Fisher Scientific Inc.